Friday, 10 Oct 2025
  • About Us
  • Contact Us
  • Terms and Conditions
  • Privacy Policy
Subscribe
Life Care News
  • Home
  • Business
    • Business Wire
    • Globenews Wire
  • News
    NewsShow More
    Fintech Forward 2025 Delivers with 38 Industry-Shaping Partnerships and Strategic Agreements Signed
    Fintech Forward 2025 Delivers with 38 Industry-Shaping Partnerships and Strategic Agreements Signed
    10/10/2025
    Kimberly-Clark Launches Enhanced Global Partnerships to Advance Essential Care for 24 Million Women and Girls
    Kimberly-Clark Launches Enhanced Global Partnerships to Advance Essential Care for 24 Million Women and Girls
    10/10/2025
    GEDU Group to Become Largest Foreign Education Investor in India
    GEDU Group to Become Largest Foreign Education Investor in India
    09/10/2025
    Signs of Change: Equipping Teachers with Tools for Inclusive Classrooms
    Signs of Change: Equipping Teachers with Tools for Inclusive Classrooms
    09/10/2025
    Nobel Prize 2025 in Medicine: Three Scientists Who Changed the Future of Immunology
    Nobel Prize 2025 in Medicine: Three Scientists Who Changed the Future of Immunology
    08/10/2025
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
  • 🔥
  • news
  • global
  • Business
  • june
  • announced
  • today
  •  and
  •  the
  • july
  • company
Font ResizerAa
Life Care NewsLife Care News
  • Home
  • Business
  • News
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
Search
  • Home
  • Business
    • Business Wire
    • Globenews Wire
  • News
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
Follow US
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
Health

Five-year Pharmacovigilance study by NTC confirms safety of fixed-dose eye drops for Post-cataract Surgery

PRNW Agency
Last updated: 18/07/2025 9:19 AM
PRNW Agency
Share
3 Min Read
Five-year Pharmacovigilance study by NTC confirms safety of fixed-dose eye drops for Post-cataract Surgery
SHARE
Five-year Pharmacovigilance study by NTC confirms safety of fixed-dose eye drops for Post-cataract Surgery

MILAN, July 17, 2025 /PRNewswire/ — A recently published five-year pharmacovigilance study confirms the excellent safety profile of a fixed-dose combination eye drop containing an anti-inflammatory steroid and a quinolone antibiotic, developed by NTC, indicated for the prevention and treatment of inflammation and prevention of infection following cataract surgery in adults. The study was submitted when nearly 4 million patients across about 60 countries worldwide were treated with this drug.

- Advertisement -

Conducted by Italian researchers and supported by NTC, the study analyzed public safety data registered in the adrreports.eu portal, that collects safety reports from EudraVigilance, the European Medicines Agency’s official adverse drug reaction (ADR) database. The study identified only 53 ADRs occurred in 25 patients between 2020 and 2024. Key findings include:

- Advertisement -
  • 74% of ADRs were non-serious.
  • More than half were deemed unlikely to be related to the product.
  • The most frequently reported events were mild reactions involving the eye or skin—expected outcomes for a topically administered ophthalmic solution.
  • No case of endophthalmitis, a severe and rare infection that can occur following eye surgery, was reported.

“This is the first international pharmacovigilance study focused specifically on a fixed-dose eye drop combining an antibiotic and an anti-inflammatory steroid,” said Dr. Giorgio Ciprandi, senior author of the publication. “Its wide usage and favorable safety profile make of it a valuable option in the modern management of post-cataract patients’.”

- Advertisement -

The findings support the current recommendation of a short-term, seven-day treatment course, which improves patient adherence and limits the risk of side effects or antibiotic resistance.

- Advertisement -

The study also highlights the importance of pharmacovigilance in evaluating medicines after market approval. “This analysis confirms how continuous safety monitoring is essential to protect patients and support clinicians based on safety information collected from the spontaneous reporting,” said Alessandro Colombo, CSO in NTC.

- Advertisement -

Cataract surgery remains the most common ophthalmic procedure worldwide, and post-operative management is critical to ensure optimal recovery. Since its approval in 2020, this innovative combination has provided patients with a simplified one-week treatment regimen that reduces unnecessary exposure to antibiotics and minimizes the risks associated with prolonged steroid use.

- Advertisement -

Thanks to its consistent safety profile, the product has received marketing authorization renewal from European regulatory authorities.

- Advertisement -

About the Study
The study, titled “Pharmacovigilance on dexamethasone 1mg/mL + levofloxacin 5 mg/mL eye drops, solution: a five-year registry.”, was conducted by experts in ophthalmology and drug safety.

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/five-year-pharmacovigilance-study-by-ntc-confirms-safety-of-fixed-dose-eye-drops-for-post-cataract-surgery-302505372.html

- Advertisement -
Presidio Named AWS Generative AI Innovation Alliance Partner
Latest Economy Observer report from Dun & Bradstreet highlights domestic resilience under threats of higher-than-expected US tariffs
Former Google Exec Outlines the High-Stakes Battle Behind Google Reviews on Maury Blackman’s Great Minds Think Data
JEEP NEVER LEAVES ANYONE BEHIND. EVEN IN VIDEOGAMES.
‘Haven of Hope’ – Shelter Home for Underprivileged Cancer Patients Inaugurated in Kochi
TAGGED: fora $antibioticantiinflammatorycombinationconfirmscontainingdevelopeddropdropsdrugexcellenteyefive-yearfiveyearfixed-dosefixeddoseindicatedinfectioninflammationjulymilannewsntcpatientspharmacovigilancepost-cataractpreventionprofilepublishedquinolonerecentlysafetysteroidstudysurgerytreatment
Share This Article
Facebook Copy Link Print
- Advertisement -

Your Trusted Source for Accurate and Timely Updates!

Our commitment to accuracy, impartiality, and delivering breaking news as it happens has earned us the trust of a vast audience. Stay ahead with real-time updates on the latest events, trends.
FacebookLike
XFollow
PinterestPin
InstagramFollow
YoutubeSubscribe
LinkedInFollow
MediumFollow

Most Selling Products

Top Picks, Trending Now – Discover the Best Sellers!
Tecno Camon 20 Premier 5G

Tecno Camon 20 Premier 5G

Dark Welkin | 8GB RAM + 512GB Storage (Expandable RAM up to 16GB) | Industry’s 1st 50MP RGBW-Pro Camera | Segment-First 108MP Ultra-Wide Macro Lens | 6.67" 120Hz 10-bit AMOLED In-Display

iQOO Z10 Lite 5G

iQOO Z10 Lite 5G

Titanium Blue | 6GB RAM + 128GB Storage | Dimensity 6300 5G with 433K+ AnTuTu Score | Robust 6000mAh Battery | IP64 Rated + Military-Grade Shock Resistance

OnePlus 13s

OnePlus 13s

Black Velvet | 12GB RAM + 256GB Storage | Flagship Snapdragon® 8 Elite Chipset | Exceptional Battery Life in a Compact Form | Lifetime Display Warranty Included

Samsung Galaxy A55 5G

Samsung Galaxy A55 5G

Awesome Iceblue | 8GB RAM + 256GB Storage | Premium Metal Frame | 50MP OIS Main Camera with Nightography | IP67 Water & Dust Resistance | Gorilla Glass Victus+ | sAMOLED Display with Vision Booster

You Might Also Like

Red Bali Kratom Launch by Happy Go Leafy Sold Out Within Hours
Health

Red Bali Kratom Launch by Happy Go Leafy Sold Out Within Hours

15/09/2025
Fitterfly Launches ‘Uplift’ – A Mental Wellness Program for Students and Communities
Health

Fitterfly Launches ‘Uplift’ – A Mental Wellness Program for Students and Communities

05/09/2025

Lamborghini Lounge Porto Cervo: where the Spirit of SantAgata meets the heart of Sardinia

16/07/2025
Cisco Receives Frost & Sullivan’s 2025 Global Company of the Year Recognition for Leadership in Mobile IoT Platforms
News

Cisco Receives Frost & Sullivan’s 2025 Global Company of the Year Recognition for Leadership in Mobile IoT Platforms

19/08/2025
Life Care News
Facebook Twitter Youtube Rss Medium

Life Care News:


We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.

Top Categories
  • Home
  • Business
  • News
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
Usefull Links
  • About Us
  • Contact Us
  • Terms and Conditions
  • Privacy Policy
Copyright © 2015 – 2025 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Life Care NewsLife Care News
Copyright © 2015 - 2025 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?